
Doccla, a dynamic enterprise based in Sheffield and London, UK, has successfully secured £35 million in a Series B funding round aimed at enhancing its innovative virtual ward and remote patient monitoring services. This significant financial boost was spearheaded by Lakestar, a prominent venture capital firm, with additional participation from esteemed investors such as Elaia, General Catalyst, Bertelsmann Investments, and Speedinvest. The infusion of capital not only reflects the growing demand for telehealth solutions but also positions Doccla to further broaden its reach and impact on a global scale. In addition to this funding, Oliver Heimes, a partner at Lakestar, will be joining the board of directors at Doccla, signifying a strategic partnership that aims to propel the company's growth trajectory.
Under the visionary leadership of Co-Founder and CEO Dag Larsson, alongside Founder Martin Ratz, Doccla is revolutionizing healthcare delivery through its virtual ward service.
This innovative approach integrates advanced monitoring devices and a user-friendly mobile application designed to systematically collect comprehensive health data from patients. The data collected is seamlessly integrated into electronic health records, allowing clinicians to have readily accessible insights at their fingertips. Medical professionals can monitor critical readings in real time, receive alerts for any alarming changes in their patients’ conditions, and schedule appointments as necessary. This level of connectivity ensures that patients receive timely and effective care, regardless of their location.
The significance of Doccla’s services extends far beyond the borders of the UK, reflecting the company's commitment to serving clients across more than ten countries in Europe. By offering features such as in-app messaging and video consultations, they ensure continuous communication between patients and healthcare providers. This not only enhances patient engagement but also fosters a sense of community and support, vital factors in the healing process. As healthcare continues to evolve, innovations spearheaded by companies like Doccla are central to addressing the challenges faced by traditional healthcare systems, making it possible to provide quality care to a broader audience while keeping costs manageable.
Click here for a full list of 7,526+ startup investors in the UK